AstraZeneca's vaccine has been renamed Vaxzevria


British-Swedish company AstraZeneca, which together with Oxford University has developed a vaccine against coronavirus, changed the name of the drug to Vaxzevria.

This is stated in a press release from the Swedish Medicines Agency, published on its website. According to its information, the vaccine's name change does not carry any other changes. 


Back to the list

The information on this site is intended solely for the personal non-commercial, non-medical or personal hygiene use of the user who accepts full responsibility for its use. 
While we have taken every precaution to ensure that the content of this site is both current and accurate, errors can occur. The information contained in this site is general in nature and should not be considered to be legal, healthcare, epidemic, tax, accounting, consulting or any other professional advice. In all cases you should consult with professionals familiar with your particular factual situation for advice concerning specific matters before making any decisions. The materials of AEB information partners and the data on hyperlink websites may not reflect opinions of AEB. AEB is not liable and will not accept any responsibility with regard to any action or abstention from action related to information contained in this site.

Contact person: Olga Silnitskaya